STOK
Stoke Therapeutics, Inc.
Company overview
- Market capitalization
- $1.65B
- Employees
- 170
- Latest publication
- 2026-09-29
About Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase 3 clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 9,325,000USD | 6,229,000USD | 1,402,000USD | 10,632,000USD | 13,817,000USD | 158,569,000USD | 22,614,000USD | 4,894,000USD |
| Research Development | 49,501,000USD | 39,673,000USD | 41,290,000USD | 37,254,000USD | 25,855,000USD | 32,676,000USD | 23,423,000USD | 22,205,000USD |
| Selling General Administrative | 25,253,000USD | 19,974,000USD | 21,146,000USD | 16,027,000USD | 15,262,000USD | 14,653,000USD | 12,844,000USD | 12,692,000USD |
| Total Operating Expenses | 74,754,000USD | 58,600,000USD | 61,786,000USD | 52,734,000USD | 41,117,000USD | 47,329,000USD | 36,267,000USD | 34,897,000USD |
| Operating Income | -65,429,000USD | -53,418,000USD | -61,439,000USD | -43,091,000USD | -27,300,000USD | 111,240,000USD | -13,653,000USD | -30,003,000USD |
| Total Other Income Expense Net | 3,811,000USD | 3,415,000USD | 3,505,000USD | 3,466,000USD | 3,817,000USD | 2,917,000USD | 3,171,000USD | 3,573,000USD |
| Income Before Tax | -61,618,000USD | -50,003,000USD | -57,934,000USD | -39,625,000USD | -23,483,000USD | 114,157,000USD | -10,482,000USD | -26,430,000USD |
| Income Tax Expense | 0USD | — | — | -1,278,000USD | — | 1,278,000USD | — | -1,111,000USD |
| Net Income | -61,618,000USD | -50,003,000USD | -57,934,000USD | -38,347,000USD | -23,483,000USD | 112,879,000USD | -10,482,000USD | -26,430,000USD |
| Cost Of Revenue | — | 1,046,999USD | 1,055,000USD | 989,000USD | 1,058,000USD | 1,076,000USD | 1,108,000USD | 1,111,000USD |
| Gross Profit | — | 5,182,000USD | 347,000USD | 9,643,000USD | 13,817,000USD | 158,569,000USD | 22,614,000USD | 4,894,000USD |
| Unclassified Operating Expenses | — | -1,047,000USD | — | — | — | — | — | — |
| Interest Expense | — | 3,397,000USD | 3,000USD | 3,000USD | 3,000USD | 2,889,000USD | — | 3,545,000USD |
| Net Interest Income | — | 3,397,000USD | 3,615,000USD | 3,463,000USD | 3,789,000USD | 2,889,000USD | 2,970,000USD | 3,545,000USD |
| Tax Provision | — | 0USD | — | -1,278,000USD | 0USD | 1,278,000USD | — | — |
| Net Income From Continuing Ops | — | -50,003,000USD | -57,934,000USD | -38,347,000USD | -23,483,000USD | 112,879,000USD | -10,482,000USD | -26,430,000USD |
| Ebit | — | -53,417,999USD | -61,439,000USD | -39,622,000USD | -27,300,000USD | 111,240,000USD | -13,653,000USD | -30,003,000USD |
| Ebitda | — | -52,371,000USD | -60,384,000USD | -38,633,000USD | -26,854,000USD | 111,717,000USD | -13,127,000USD | -29,463,000USD |
| Depreciation And Amortization | — | 1,046,999USD | 1,055,000USD | 989,000USD | 446,000USD | 477,000USD | 526,000USD | 540,000USD |
| Reconciled Depreciation | — | 439,000USD | 405,000USD | 442,000USD | 446,000USD | 477,000USD | 526,000USD | 540,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 184,420,000USD | 36,555,000USD | 8,780,000USD | 12,405,000USD | 3,000,000USD | 0USD | 0USD | 0USD |
| Gross Profit | 184,420,000USD | 36,555,000USD | 8,780,000USD | 12,405,000USD | -2,230,000USD | -1,926,000USD | -450,000USD | -214,000USD |
| Research Development | 137,922,000USD | 89,133,000USD | 82,231,000USD | 77,837,000USD | 54,168,000USD | 32,197,000USD | 23,764,000USD | 8,371,000USD |
| Selling General Administrative | 67,088,000USD | 48,794,000USD | 41,322,000USD | 38,924,000USD | 31,897,000USD | 20,847,000USD | 11,914,000USD | 4,410,000USD |
| Total Operating Expenses | 205,010,000USD | 137,927,000USD | 123,553,000USD | 116,761,000USD | 86,065,000USD | 53,044,000USD | 35,678,000USD | 12,781,000USD |
| Operating Income | -20,590,000USD | -101,372,000USD | -114,773,000USD | -104,356,000USD | -86,065,000USD | -53,044,000USD | -35,678,000USD | -12,781,000USD |
| Interest Expense | 13,756,000USD | 12,638,000USD | 9,908,000USD | 3,122,000USD | 120,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | 13,756,000USD | 12,638,000USD | 8,800,000USD | 3,122,000USD | 120,000USD | 744,000USD | 3,351,000USD | 270,000USD |
| Income Before Tax | -6,885,000USD | -88,981,000USD | -104,699,000USD | -101,067,000USD | -85,805,000USD | -52,243,000USD | -32,325,000USD | -12,521,000USD |
| Net Income | -6,885,000USD | -88,981,000USD | -104,699,000USD | -93,110,000USD | -84,711,000USD | -50,611,000USD | -28,524,000USD | -12,521,000USD |
| Net Income From Continuing Ops | -6,885,000USD | -88,981,000USD | -103,396,000USD | -101,067,000USD | -85,805,000USD | -52,243,000USD | -32,325,000USD | -12,521,000USD |
| Ebit | -20,590,000USD | -101,372,000USD | -114,773,000USD | -104,356,000USD | -86,065,000USD | -53,044,000USD | -35,678,000USD | -12,781,000USD |
| Ebitda | -18,820,000USD | -99,195,000USD | -112,304,000USD | -102,810,000USD | -85,091,000USD | -52,156,000USD | -35,228,000USD | -12,567,000USD |
| Depreciation And Amortization | 1,770,000USD | 2,177,000USD | 2,469,000USD | 1,546,000USD | 974,000USD | 888,000USD | 450,000USD | 214,000USD |
| Reconciled Depreciation | 1,770,000USD | 2,177,000USD | 2,454,000USD | 1,546,000USD | 974,000USD | 888,000USD | 450,000USD | 214,000USD |
| Total Other Income Expense Net | 13,705,000USD | 12,391,000USD | 10,074,000USD | 3,289,000USD | 260,000USD | 801,000USD | 3,353,000USD | 260,000USD |
| Cost Of Revenue | — | 4,442,000USD | 4,729,000USD | 3,535,000USD | 2,230,000USD | 1,926,000USD | 450,000USD | 214,000USD |
| Income Tax Expense | — | -88,981,000USD | 4,561,105USD | -7,957,000USD | -1,094,000USD | -1,632,000USD | -3,801,000USD | 260,000USD |
| Non Operating Income Net Other | — | — | — | 167,000USD | 140,000USD | 801,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -101,067,000USD | -85,805,000USD | -52,243,000USD | -32,325,000USD | -12,521,000USD |
| Interest Income | — | — | — | — | 120,000USD | 744,000USD | 3,351,000USD | 270,000USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 393,966,000USD | 443,277,000USD | 418,434,000USD | 360,264,000USD | 384,508,000USD | 406,888,000USD | 271,555,000USD | 293,319,000USD |
| Cash And Equivalents | 110,004,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 322,538,000USD | 366,681,000USD | 305,700,000USD | 272,437,000USD | 269,970,000USD | 375,736,000USD | 232,756,000USD | 253,612,000USD |
| Other Current Assets | 6,313,000USD | 16,995,000USD | 13,125,000USD | 13,290,000USD | 20,640,000USD | 17,806,000USD | 15,157,000USD | 13,721,000USD |
| Total Liabilities | 48,419,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 41,930,000USD | 40,806,000USD | 57,875,000USD | 41,727,000USD | 38,678,000USD | 44,685,000USD | 40,056,000USD | 49,865,000USD |
| Other Non Current Liabilities | 837,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 345,547,000USD | 394,877,000USD | 352,457,000USD | 308,105,000USD | 334,943,000USD | 350,074,000USD | 229,021,000USD | 232,113,000USD |
| Total Equity Including Noncontrolling Interest | 345,547,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 8,523,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 5,652,000USD | — | — | — | — | — | — | — |
| Net Receivables | 7,179,000USD | 6,141,000USD | 7,905,000USD | 10,837,000USD | 1,622,000USD | 606,000USD | 700,000USD | 691,000USD |
| Property Plant Equipment Net | 6,699,000USD | 5,888,000USD | 6,247,000USD | 6,791,000USD | 6,561,000USD | 7,442,000USD | 8,254,000USD | 9,261,000USD |
| Accounts Payable | 4,794,000USD | 6,839,000USD | 4,939,000USD | 5,871,000USD | 4,313,000USD | 2,186,000USD | 2,498,000USD | 2,485,000USD |
| Common Stock | 6,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -609,336,000USD | -547,718,000USD | -497,715,000USD | -439,781,000USD | -401,434,000USD | -377,951,000USD | -490,830,000USD | -480,348,000USD |
| Accumulated Other Comprehensive Income | -542,000USD | -115,000USD | 543,000USD | 446,000USD | 96,000USD | -104,000USD | -151,000USD | 166,000USD |
| Total Liab | — | 48,400,000USD | 65,977,000USD | 52,159,000USD | 49,565,000USD | 56,814,000USD | 42,534,000USD | 61,206,000USD |
| Other Current Liab | — | 21,468,000USD | 41,035,000USD | 27,185,000USD | 23,320,000USD | 21,984,000USD | 16,245,000USD | 13,470,000USD |
| Capital Stock | — | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Cash | — | 155,659,000USD | 84,220,000USD | 83,394,000USD | 101,472,000USD | 274,817,000USD | 127,983,000USD | 150,016,000USD |
| Cash And Short Term Investments | — | 343,545,000USD | 284,670,000USD | 248,310,000USD | 247,708,000USD | 357,324,000USD | 216,899,000USD | 239,200,000USD |
| Current Deferred Revenue | — | 10,066,000USD | 11,901,000USD | 5,763,000USD | 8,749,000USD | 18,164,000USD | 18,991,000USD | 31,612,000USD |
| Net Debt | — | -152,236,000USD | -84,220,000USD | -80,486,000USD | -99,176,000USD | -272,466,000USD | -125,661,000USD | -147,718,000USD |
| Short Term Debt | — | 2,433,000USD | — | 2,908,000USD | 2,296,000USD | 2,351,000USD | 2,322,000USD | 2,298,000USD |
| Short Long Term Debt Total | — | 3,423,000USD | — | 2,908,000USD | 2,296,000USD | 2,351,000USD | 2,322,000USD | 2,298,000USD |
| Long Term Investments | — | 67,481,000USD | 106,260,000USD | 80,315,000USD | 107,256,000USD | 22,989,000USD | 29,824,000USD | 29,952,000USD |
| Short Term Investments | — | 187,886,000USD | 200,450,000USD | 164,916,000USD | 146,236,000USD | 82,507,000USD | 88,916,000USD | 89,184,000USD |
| Property Plant Equipment Gross | — | 5,888,000USD | 16,393,000USD | 6,791,000USD | 6,561,000USD | 7,442,000USD | 17,102,000USD | 9,261,000USD |
| Common Stock Shares Outstanding | — | 63,063,507shares | 58,389,000shares | 58,611,677shares | 58,353,855shares | 59,398,600shares | 57,029,296shares | 56,341,074shares |
| Non Current Assets Total | — | 76,596,000USD | 112,734,000USD | 87,827,000USD | 114,538,000USD | 31,152,000USD | 38,799,000USD | 39,707,000USD |
| Non Current Liabilities Total | — | 7,594,000USD | 8,102,000USD | 10,432,000USD | 10,887,000USD | 12,129,000USD | 2,478,000USD | 11,341,000USD |
| Non Current Liabilities Other | — | 991,000USD | 1,141,000USD | 1,874,000USD | 1,255,000USD | 1,874,000USD | 2,478,000USD | 3,050,000USD |
| Non Currrent Assets Other | — | 70,708,000USD | 106,487,000USD | 721,000USD | 721,000USD | 721,000USD | 721,000USD | 494,000USD |
| Net Working Capital | — | 325,875,000USD | 247,825,000USD | 230,710,000USD | 231,292,000USD | 331,051,000USD | 192,700,000USD | 203,747,000USD |
| Unclassified Non Current Assets | — | -67,481,000USD | -106,260,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 6,603,000USD | 6,961,000USD | 8,558,000USD | 9,632,000USD | 10,255,000USD | — | 8,291,000USD |
| Unclassified Equity | — | 942,698,000USD | 849,619,000USD | 747,430,000USD | 736,271,000USD | 728,119,000USD | 719,992,000USD | 712,285,000USD |
| Inventory | — | — | — | — | — | — | — | 75,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 418,434,000USD | 271,555,000USD | 228,342,000USD | 256,067,000USD | 238,865,000USD | 297,925,000USD | 228,750,000USD | 107,539,000USD |
| Other Current Assets | 13,125,000USD | 15,157,000USD | 13,881,000USD | 13,887,000USD | 9,276,000USD | 6,616,000USD | 3,281,000USD | 548,000USD |
| Total Liab | 65,977,000USD | 42,534,000USD | 68,777,000USD | 71,218,000USD | 21,088,000USD | 11,847,000USD | 4,322,000USD | 2,471,000USD |
| Total Stockholder Equity | 352,457,000USD | 229,021,000USD | 159,565,000USD | 184,849,000USD | 217,777,000USD | 286,078,000USD | 224,428,000USD | 105,068,000USD |
| Other Current Liab | 41,035,000USD | 16,245,000USD | 11,753,000USD | 13,389,000USD | 13,247,000USD | 8,864,000USD | 3,350,000USD | 1,396,000USD |
| Common Stock | 5,000USD | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 1,000USD |
| Capital Stock | 5,000USD | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 2,000USD |
| Retained Earnings | -497,715,000USD | -490,830,000USD | -401,849,000USD | -297,150,000USD | -196,083,000USD | -110,278,000USD | -58,035,000USD | -25,710,000USD |
| Cash | 84,220,000USD | 127,983,000USD | 191,442,000USD | 113,556,000USD | 144,895,000USD | 287,308,000USD | 222,471,000USD | 105,399,000USD |
| Cash And Short Term Investments | 284,670,000USD | 216,899,000USD | 201,394,000USD | 229,595,000USD | 219,810,000USD | 287,308,000USD | 222,471,000USD | 105,399,000USD |
| Total Current Assets | 305,700,000USD | 232,756,000USD | 215,339,000USD | 244,070,000USD | 229,218,000USD | 293,930,000USD | 226,033,000USD | 106,143,000USD |
| Total Current Liabilities | 57,875,000USD | 40,056,000USD | 30,819,000USD | 31,394,000USD | 17,139,000USD | 11,425,000USD | 4,101,000USD | 2,467,000USD |
| Current Deferred Revenue | 11,901,000USD | 18,991,000USD | 15,309,000USD | 14,880,000USD | 12,707,000USD | -1,066,000USD | — | — |
| Net Debt | -84,220,000USD | -125,661,000USD | -189,380,000USD | -111,197,000USD | -143,388,000USD | -286,242,000USD | -222,471,000USD | -105,399,000USD |
| Long Term Investments | 106,260,000USD | 29,824,000USD | 0USD | — | — | — | — | 0USD |
| Short Term Investments | 200,450,000USD | 88,916,000USD | 9,952,000USD | 116,039,000USD | 74,915,000USD | 0USD | — | 0USD |
| Net Receivables | 7,905,000USD | 700,000USD | 64,000USD | 588,000USD | 132,000USD | 6,000USD | 281,000USD | 196,000USD |
| Accounts Payable | 4,939,000USD | 2,498,000USD | 1,695,000USD | 766,000USD | 2,385,000USD | 1,495,000USD | 751,000USD | 1,071,000USD |
| Property Plant Equipment Net | 6,247,000USD | 8,254,000USD | 12,434,000USD | 11,428,000USD | 9,078,000USD | 3,790,000USD | 2,512,000USD | 1,192,000USD |
| Property Plant Equipment Gross | 16,393,000USD | 17,102,000USD | 19,105,000USD | 11,428,000USD | 9,078,000USD | 3,790,000USD | 2,512,000USD | 1,192,000USD |
| Accumulated Other Comprehensive Income | 543,000USD | -151,000USD | -24,000USD | -1,175,000USD | -168,000USD | 0USD | 0USD | -379,000USD |
| Common Stock Shares Outstanding | 59,219,184shares | 54,008,883shares | 43,994,862shares | 38,897,442shares | 36,739,269shares | 33,488,456shares | 17,971,443shares | 23,511,755shares |
| Non Current Assets Total | 112,734,000USD | 38,799,000USD | 13,003,000USD | 11,997,000USD | 9,647,000USD | 3,995,000USD | 2,717,000USD | 1,396,000USD |
| Non Current Liabilities Total | 8,102,000USD | 2,478,000USD | 37,958,000USD | 39,824,000USD | 3,949,000USD | 422,000USD | 221,000USD | 4,000USD |
| Non Current Liabilities Other | 1,141,000USD | 2,478,000USD | 4,884,000USD | 2,968,000USD | 3,949,000USD | 422,000USD | 221,000USD | 4,000USD |
| Non Currrent Assets Other | 106,487,000USD | 721,000USD | 569,000USD | 569,000USD | 569,000USD | 205,000USD | 205,000USD | 204,000USD |
| Net Working Capital | 247,825,000USD | 192,700,000USD | 184,520,000USD | 212,676,000USD | 212,079,000USD | 282,505,000USD | 221,932,000USD | 103,676,000USD |
| Unclassified Non Current Assets | -106,260,000USD | — | — | — | -248,512,000USD | -1,320,000USD | — | — |
| Unclassified Non Current Liabilities | 6,961,000USD | — | 33,074,000USD | -37,107,000USD | -3,949,000USD | — | — | — |
| Unclassified Equity | 849,619,000USD | 719,992,000USD | 561,428,000USD | 483,166,000USD | 414,020,000USD | 396,348,000USD | 282,457,000USD | 131,154,000USD |
| Short Term Debt | — | 2,322,000USD | 2,062,000USD | 2,359,000USD | 1,507,000USD | 1,066,000USD | — | 0USD |
| Short Long Term Debt Total | — | 2,322,000USD | 2,062,000USD | 2,359,000USD | 1,507,000USD | 1,066,000USD | — | — |
| Deferred Long Term Liab | — | — | — | 36,856,000USD | — | — | — | 0USD |
| Other Liab | — | — | — | 37,107,000USD | 3,949,000USD | 342,000USD | 221,000USD | 4,000USD |
| Other Assets | — | — | — | 569,000USD | 248,512,000USD | 1,320,000USD | 205,000USD | 204,000USD |
| Inventory | — | — | — | 10,932,000USD | -74,915,000USD | — | — | 0USD |
| Net Tangible Assets | — | — | — | 184,849,000USD | 217,777,000USD | 286,078,000USD | 224,428,000USD | 105,066,000USD |
| Unclassified Current Assets | — | — | — | -10,932,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -12,707,000USD | — | — | — |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -50,003,000USD | -57,934,000USD | -38,347,000USD | -23,482,000USD | 112,879,000USD | -10,482,000USD | -26,430,000USD | -25,695,000USD |
| Depreciation | 439,000USD | 405,000USD | 989,000USD | 446,000USD | 477,000USD | 526,000USD | 540,000USD | 548,000USD |
| Stock Based Compensation | 8,753,000USD | 9,848,000USD | 8,039,000USD | 7,598,000USD | 6,753,000USD | 7,139,000USD | 7,494,000USD | 7,427,000USD |
| Other Non Cash Items | 243,000USD | 252,000USD | 8,111,000USD | 1,139,000USD | 105,000USD | -200,000USD | 24,000USD | 273,000USD |
| Change To Account Receivables | 1,486,000USD | 3,312,000USD | -7,580,000USD | — | -1,325,000USD | — | — | — |
| Change In Working Capital | -20,014,000USD | 16,975,000USD | -1,119,000USD | -11,123,000USD | 11,613,000USD | -20,176,000USD | -3,243,000USD | -30,000USD |
| Total Cash From Operating Activities | -60,582,000USD | -30,454,000USD | -30,366,000USD | -25,422,000USD | 131,827,000USD | -23,193,000USD | -21,615,000USD | -17,477,000USD |
| Capital Expenditures | -353,000USD | -232,000USD | -132,000USD | -154,000USD | -152,000USD | -42,000USD | -103,000USD | -46,000USD |
| Free Cash Flow | -60,935,000USD | -30,686,000USD | -30,498,000USD | -25,576,000USD | 131,675,000USD | -23,235,000USD | -21,718,000USD | -17,523,000USD |
| Investments | 51,047,000USD | -60,829,000USD | 9,094,000USD | -148,477,000USD | 13,632,000USD | 819,000USD | -30,004,000USD | -88,278,000USD |
| Total Cashflows From Investing Activities | 50,694,000USD | -61,061,000USD | 9,094,000USD | -148,477,000USD | 13,632,000USD | 819,000USD | -30,004,000USD | -88,278,000USD |
| Total Cash From Financing Activities | 84,327,000USD | 92,341,000USD | 3,120,000USD | 554,000USD | 1,374,000USD | 568,000USD | 8,159,000USD | 120,650,000USD |
| Issuance Of Capital Stock | 80,657,000USD | 87,784,000USD | 0USD | 0USD | 0USD | 1,000USD | 7,656,000USD | 119,884,000USD |
| Change In Cash | 74,439,000USD | 826,000USD | -18,153,000USD | -173,345,000USD | 146,833,000USD | -21,806,000USD | -43,460,000USD | 14,895,000USD |
| Begin Period Cash Flow | 84,941,000USD | 84,115,000USD | 101,547,000USD | 275,613,000USD | 128,780,000USD | 150,585,000USD | 194,045,000USD | 179,150,000USD |
| End Period Cash Flow | 159,380,000USD | 84,941,000USD | 83,394,000USD | 102,268,000USD | 275,613,000USD | 128,779,000USD | 150,585,000USD | 194,045,000USD |
| Other Cashflows From Financing Activities | 84,327,000USD | 92,341,000USD | 3,120,000USD | 554,000USD | 1,374,000USD | 567,000USD | 503,000USD | 766,000USD |
| Unclassified Financing Cash Flow | -80,657,000USD | -87,784,000USD | — | — | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | -8,039,000USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | -88,232,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | 88,278,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -6,885,000USD | -88,981,000USD | -104,699,000USD | -101,067,000USD | -85,805,000USD | -52,243,000USD | -32,325,000USD | -12,521,000USD |
| Depreciation | 1,770,000USD | 2,177,000USD | 2,469,000USD | 1,546,000USD | 974,000USD | 888,000USD | 450,000USD | 214,000USD |
| Stock Based Compensation | 32,238,000USD | 27,470,000USD | 25,257,000USD | 22,854,000USD | 16,450,000USD | 5,768,000USD | 1,922,000USD | 240,000USD |
| Other Non Cash Items | 2,116,000USD | 623,000USD | 1,936,000USD | 1,778,000USD | 1,256,000USD | 1,038,000USD | 3,000USD | 10,000USD |
| Change To Account Receivables | -4,268,000USD | -50,000USD | — | — | — | — | — | 0USD |
| Change In Working Capital | 16,346,000USD | -28,140,000USD | -6,030,000USD | 43,023,000USD | 46,000USD | 2,325,000USD | -1,105,000USD | 1,093,000USD |
| Total Cash From Operating Activities | 45,585,000USD | -86,851,000USD | -81,067,000USD | -31,866,000USD | -66,907,000USD | -42,221,000USD | -31,055,000USD | -10,964,000USD |
| Capital Expenditures | -670,000USD | -203,000USD | -1,616,000USD | -3,962,000USD | -1,200,000USD | -1,050,000USD | -1,635,000USD | -935,000USD |
| Free Cash Flow | 44,915,000USD | -87,054,000USD | -82,683,000USD | -35,828,000USD | -68,107,000USD | -43,271,000USD | -32,690,000USD | -11,899,000USD |
| Investments | -186,142,000USD | -107,475,000USD | 113,665,000USD | -41,920,000USD | -75,226,000USD | -1,050,000USD | -1,634,000USD | -925,000USD |
| Total Cashflows From Investing Activities | -186,812,000USD | -107,475,000USD | 105,946,000USD | -45,882,000USD | -76,426,000USD | -1,050,000USD | -1,634,000USD | -925,000USD |
| Total Cash From Financing Activities | 97,389,000USD | 131,094,000USD | 53,007,000USD | 46,409,000USD | 1,284,000USD | 108,108,000USD | 149,762,000USD | 115,639,000USD |
| Issuance Of Capital Stock | 87,784,000USD | 128,840,000USD | 44,743,000USD | 45,344,000USD | 42,245,000USD | 105,398,000USD | 151,912,000USD | 116,019,000USD |
| Change In Cash | -43,838,000USD | -63,232,000USD | 77,886,000USD | -31,339,000USD | -142,049,000USD | 64,837,000USD | 117,073,000USD | 103,750,000USD |
| Begin Period Cash Flow | 128,779,000USD | 192,011,000USD | 114,125,000USD | 145,464,000USD | 287,513,000USD | 222,676,000USD | 105,603,000USD | 1,853,000USD |
| End Period Cash Flow | 84,941,000USD | 128,779,000USD | 192,011,000USD | 114,125,000USD | 145,464,000USD | 287,513,000USD | 222,676,000USD | 105,603,000USD |
| Other Cashflows From Financing Activities | 97,389,000USD | 2,254,000USD | 926,000USD | 1,065,000USD | -2,000USD | 2,710,000USD | -2,150,000USD | 115,639,000USD |
| Unclassified Financing Cash Flow | -87,784,000USD | — | 7,338,000USD | 44,280,000USD | — | -2,710,000USD | — | -116,019,000USD |
| Unclassified Investing Cash Flow | — | — | -6,103,000USD | 45,344,000USD | 75,226,000USD | 1,050,000USD | 1,634,000USD | — |
| Change To Liabilities | — | — | — | 48,206,000USD | 2,897,000USD | 5,203,000USD | 891,000USD | 1,735,000USD |
| Sale Purchase Of Stock | — | — | — | 1,064,000USD | 1,286,000USD | 108,287,000USD | 152,227,000USD | 116,019,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -31,339,000USD | -142,049,000USD | 64,837,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | -45,344,000USD | -75,226,000USD | — | 1,000USD | 10,000USD |
| Net Borrowings | — | — | — | — | — | -179,000USD | — | 0USD |
| Change To Inventory | — | — | — | — | — | — | — | 0USD |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Global Development Activity | 4,033,000 | USD | 0001193125-26-211874 |
| Q1 2026Quarterly · 2026-03-31 | Product | IPLicense | 0 | USD | 0001193125-26-211874 |
| Q4 2025Quarterly · 2025-12-31 | Product | Global Development Activity | 5,974,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | IPLicense | 0 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Global Development Activity | 17,496,000 | USD | 0001193125-26-108362 |
| FY 2025Yearly · 2025-12-31 | Product | IPLicense | 150,779,000 | USD | 0001193125-26-108362 |
| Q3 2025Quarterly · 2025-09-30 | Product | Global Development Activity | 6,683,000 | USD | 0001193125-25-264720 |
| Q3 2025Quarterly · 2025-09-30 | Product | IPLicense | 0 | USD | 0001193125-25-264720 |
| Q2 2025Quarterly · 2025-06-30 | Product | Global Development Activity | 3,197,000 | USD | 0000950170-25-107332 |
| Q2 2025Quarterly · 2025-06-30 | Product | IPLicense | 0 | USD | 0000950170-25-107332 |
| Q1 2025Quarterly · 2025-03-31 | Product | Global Development Activity | 1,642,000 | USD | 0001193125-26-211874 |
| Q1 2025Quarterly · 2025-03-31 | Product | IPLicense | 150,779,000 | USD | 0001193125-26-211874 |
| FY 2024Yearly · 2024-12-31 | Product | License | 29,400,000 | USD | 0000950170-25-041170 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 7,200,000 | USD | 0000950170-25-041170 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.